Market News & Trends
Argo Biopharma Announces First Subject Dosed in Phase I Study of siRNA Therapeutic BW-50218
Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage biotechnology company committed to developing next-generation siRNA therapies, today announced the first subject has been dosed in…
Bio-Rad Launches PTC Harmony 96 & PTC Harmony Deepwell Thermal Cyclers
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of the PTC…
PTC Therapeutics to Report Results From PIVOT-HD Long-Term Extension Study
PTC Therapeutics, Inc. (NASDAQ: PTCT) will host a webcast conference call today, April 28 at 4:30 p.m. ET to share results from the 24-month interim…
Evonik & Higuchi Strengthen Oral Drug Delivery Innovation in Japan With New Joint Laboratory
Evonik and Higuchi Inc., a leading Japanese trading company in the pharmaceutical sector, are opening a joint laboratory located in Yokohama, Japan. The “Open Pharma…
BD & Suttons Creek Partner to Help Pharma a& Biotech Companies Deliver Combination Products to Market With Confidence
Becton, Dickinson and Company (BD) (NYSE:BDX), one of the largest global medical technology companies in the world, and Suttons Creek, a BlueRidge Life Sciences company,…
Intellia Therapeutics Reports Positive Phase 3 Results in Hereditary Angioedema, Marking a Global First for In Vivo Gene Editing
Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced positive topline results…
Evonik Strengthens Biotechnology Capabilities for Drug Substance Manufacturing With New Investment in Slovakia
Evonik is investing around EUR 80 million to expand its biotechnology capabilities at its Fermas site in Slovenská Ľupča, Slovakia. The investment will add state-of-the-art…
Alcami to Acquire Contract Packaging Organization Tjoapack
Alcami Corporation recently announced it has entered into a definitive agreement to acquire Tjoapack, a leading global contract packaging organization with facilities in the United…
MilliporeSigma Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, recently announced the launch of the…
Crown Bioscience & Turbine Partner to Connect AI-Driven Prediction With Organoid Validation in Translational Oncology
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced a strategic partnership with Turbine, a leading virtual biology…
Gerresheimer & Milliken Partner to Advance Performance & Protection With LeneX UltraGuard Technology
Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries, recently announced a partnership with Milliken &…
Piramal Pharma Solutions & Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development & Manufacturing
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration. Under this collaboration, Piramal will refer applicable customers seeking ADC manufacturing technology to…
Nemera Announces Construction of a New Production Hall
Nemera, a global leader in drug delivery devices, recently announced the groundbreaking ceremony for a new production hall at its La Verpillière site (Isère, France).…
Ardena Opens New Bioanalytical Laboratory in New Jersey
Ardena recently announced its new state-of –the-art GLP bioanalytical laboratory in Somerset, New Jersey, is now operational and supporting client studies. The 2,500+ sqft laboratory…
First Patients Dosed With Cabaletta Bio’s Rese-cel Manufactured on Cellares' Automated Cell Shuttle Platform
Cellares recently announced that Cabaletta Bio Inc.’s investigational CAR T cell therapy rese-cel (resecabtagene autoleucel) has been infused into the first two patients using drug…
Bio-Rad Extends Range of Anti-Idiotypic Antibodies & Anti-Fc Mutation Antibodies for Bioanalysis & Drug Monitoring
Bio-Rad Laboratories, Inc. recently extended its range of recombinant monoclonal anti-idiotypic antibodies, with the introduction of eight antibodies specific to romosuzumab (Evenity), burosumab (Crysvita), ixekizumab…
Transgene Completes Patient Randomization in Phase 2 Part of Clinical Trial Evaluating TG4050 in the Adjuvant Treatment of Head & Neck Cancer
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced the completion of patient randomization…
PannTheraPi Announces Significant Clinical Development & Strategic Milestones
PannTheraPi recently announced significant progress in its clinical development alongside a key leadership appointment to strengthen its scientific and operational capabilities. The company has submitted…
ProImmune Collaborates With The University of Texas Medical Branch to Advance Infectious Disease Research
ProImmune, Ltd.recently announced a collaboration with The University of Texas Medical Branch (UTMB) Galveston National Laboratory (GNL), a high-containment, infectious disease research facility, to develop…
Symbiosis Expands Commercial Capabilities With Addition of New Stability Chamber
Symbiosis Pharmaceutical Services has expanded its Quality Control (QC) laboratory with the installation of a new 30°C stability chamber. This addition enables Symbiosis to replicate…
